Xantinol nicotinate
| Combination of | |
|---|---|
| Xanthinol | vasodilator |
| Niacin | vasodilator |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Identifiers | |
| ATC code | C04AD02 (WHO) |
| PubChem | CID 9912 |
| ChemSpider | 9525 |
| UNII |
8G60H12X2D |
| KEGG |
D06334 |
| | |
Xantinol nicotinate (xanthinol niacinate; trade name Complamina) is a vasodilator. It is a combination of xanthinol and niacin (nicotinic acid),[1] both of which are vasodilators. It increases blood flow in many vascular beds and has been promoted for cerebrovascular disorders and PVDs, but therapeutic benefits are insignificant.
References
- ↑ Xanthinol niacinate at cancerweb.ncl.ac.uk
| ||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.